Expert in pre-clinical & clinical analyses
on mitochondrial behavior & product safety
Pharmaco-toxicology services
ICDD is the first company to offer toxicity testing leveraging the full potential of the mitochondria. As of today, ICDD is offering a full range of services, Mitosafe® for early deselection of hits using a mechanistic approach, and Mitostream® for anticipation of lead/candidate clinical tolerance.
SERVICES
At key moments of your critical path
• Early deselection of hits based on impairement of mitochondrial function (Mitosafe)
• Early deselection of hits / leads based on impairement of mitochondrial integrity (Mitostream Light)
• Optimization of lead toxicity based on anticipation of clinical tolerance (Mitostream Expert)
• Expert guidance in design and/or interpretation of data to understand adverse events occurring post-marketing (Mitostream Vigilance)
INNOVATION
Get the whole pictureCurrent technologies cannot apprehend the exhaustivity of a biologic system. Our patented innovation uses the mitochondrium as a dynamic system and generates a comprehensive picture of its functionning in the living human cell.
PROFESSIONALISM
• Standard Operating Procedures
• Trained team of dedicated scientists
• Industry-validated benchmarking of our technology
• Constant updating of our database to reflect therapeutic advances and keeping our services up to date.
• Partner in European IMI program
ICDD performs reliable and robust assays in a quality-controlled environment to reduce your risks and increase the value of drug candidates in the clinical phases. Better clinical outcomes will improve the confidence in the therapeutic treatments you deliver to your patients.
APPLICATION FIELDS
• Drug development• Environemental safety
• Nutraceuticals
